Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2.5% | +15.7% | 3 / 3 | -1.5% | +2.76 pp | +0.09 pp | +6.8% | 0.21 | 13.66 | 650 | −1,5% | 15,4 | +2,5% | 13.66 | 13.59 | +0,5% |
| Pts | 0 | 0 | 12 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 14.500 (close price on 2026-10-19)EPS (TTM): 1.061
Financial charts
1.Revenue & growth
VND bn650Q2/26
1.Revenue & growth
VND bn650Q2/26
2.Profit & growth
VND bn15,4Q2/26
3.Profit mix (Penman)
VND bn110Q2/26
4.Margins & cost structure
%23.7%Q2/26
5.Returns & cash cycle
% · days10.5%Q2/26
6.Earnings quality & cash
VND bn-176Q2/26
7.Asset structure
VND bn1.844Q2/26
8.Funding & debt health
VND bn · times1.844Q2/26
9.Revenue backlog
VND bn6,30Q2/26
10.Valuation
times · %13,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %190Q2/26
Adjusted EPS growth, latest quarter
2.5%
Average adjusted EPS growth, 3 quarters
15.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26